The New Fountain Of Life
 Gerovital (GH3): The Product, Its History, Its Benefits
An easy reference

These pages have been written for lay people to allow them to gain a basic knowledge of the origins, history, usage and researched effects of a remarkable nutritional food – GEROVITAL (GH3). They are not, however, intended for use as a medical reference.

Substances occurring naturally within the human body are referred to as "natural" herein, while "unnatural" refers to products manufactured in a laboratory that are alien to the human body and are usually prescribed for symptomatic relief of a variety of medical conditions, often with disastrous consequences.

Medical terminology has wherever possible been omitted, or simplified to ensure easy understanding where its inclusion is unavoidable. Those readers engaged in healthcare  are requested to overlook the slight lack of depth that could be perceived as a result of this policy. Our object is to inform readers fully while avoiding the possibility of confusion due to the inclusion of unnecessary technical details.

[ T O P ]

IN THE BEGINNING

Gerovital H3 (GH3) is based on a substance discovered by an Austrian biochemist named Dr Alfred Einhorn. This substance was "Procaine Hydrochloride". In 1905 Einhorn was successful in synthesising and combining in aqueous solution two products occurring naturally within the human body: Para-aminobenzoic acid – PABA – a member of the B vitamin complex, and Diethylaminoethanol – DEAE. Einhorn named the resultant product "procaine" in order to distinguish it.
Procaine’s anaesthetic qualities were evident and proved extremely useful. In the US it became known as "Novocain" and used extensively to reduce discomfort during dental procedures. It proved to be highly effective, basically non-toxic and lacking in addictive qualities.

However, between its 1905 discovery and the late 1940’s there was little interest in taking the product beyond its known anaesthetic use. This was until Dr Ana Aslan of the National Geriatric Institute in Bucharest, Romania, began to experiment with it as a means of pain relief in the arthritic joints of elderly patients.

The experiments proved successful, reducing pain and increasing mobility in patients. More interestingly, however, Dr Aslan’s patients began exhibiting improved physical and mental well-being far in excess of the arthritic benefits of the product.
Being a formidable medical research scientist, Dr Aslan could not allow this to go unnoticed and immediately set up a highly controlled programme researching these highly beneficial "side-effects" of procaine.

Basically the problem was stabilisation, as procaine hydrolysed quickly in the body and remained active for a relatively short period of time. If it could be absorbed in greater amounts (hopefully) the benefits already noticed could also be increased. Dr Aslan and her colleagues added potassium metabisulphite and disodium phosphate to procaine. This had the desired effect, and it could then be sustained within the human body for up to nine hours. GEROVITAL H3 had arrived!

The "side-effects" of GH3 became quickly established , and the “legend of Bucharest” was born.

GH3 is now available in numerous  progressive countries and it is estimated that more than 50 million people, including world leaders, have used this product. The amount of conclusive evidence regarding its efficacy is prodigious and irrefutable – including much based on research carried out by eminent medical bodies in the US. Individuals or organisations (professional or governmental) seeking to challenge or ignore the evidence have done so as a result of other and less worldly motives than a desire to establish the truth. There are of course none so blind as those who do not wish to see!

In 1956 Dr Aslan presented the research findings to the European Congress for Gerontology in Karlsruhe, West Germany. Her conclusions were met with widespread scepticism, and although the fraternity listened politely, she simply was not believed; the reason is not difficult to comprehend. All of us – public and medical professionals alike – have been educated to assume that a single remedy solves a single problem – e.g. an aspirin cures a headache, or another type of powder relieves a stomach ache. Anyone suggesting that a product previously used as a dental anaesthetic held the secret of rejuvenated cell life, regardless of their sincerity of background, was simply unacceptable. Dr Ana Aslan had lost the battle – but she had no intention of losing the war!

Intent on proving the validity of her claims beyond doubt Dr Aslan embarked on one of the greatest research programs ever undertaken, probably the largest and most thorough double-blind study in the history of the world’s health industry. For almost two years 15,000 workers aged between 38 and 62 years were observed throughout Romania. Over 400 Doctors staffing a network of 154 clinics participated in the program.

All the patients were healthy but ageing (of course) and a range of astonishing results were manifest. Amongst those using GH3, sickness (measured in lost working days) declined by over 40%. This prompted the Romanian Government to heavily subsidise distribution of GH3 throughout the population as a way of assisting the working economy.

Specific changes included the normalisation (either up or down) of blood pressure, the improvement of respiratory functions, increased muscular vigour and basic sex drive, an improvement in arthritic conditions, the disappearance of peptic ulcers, and the normalisation of cholesterol levels among many others. The evidence was that the degenerative effects of aging were halted, and in up to 80% of the subjects under scrutiny they even reversed to a significant extent.

Those in the programme not receiving GH3 received a "placebo". However, no one – not even the medical staff – knew who was receiving GH3 and who was not (hence the term "double-blind").

While the study was being conducted an influenza epidemic swept across Europe. Communist and capitalist countries alike suffered from the effects of the disease, but while the death rate among those taking GH3 was 2.7%, among those receiving standard medical treatment it was 13.9% – more than five times higher! This was in itself evidence of the heightened level of health and resistance to infection imbued in persons taking this remarkable food on adaily basis. Once again Dr Aslan confronted the European Congress of Gerontology, which carefully examined the huge body of evidence she presented. Being convinced of its accuracy, the congress accepted it as a basis for the truth of her claims, and she received tremendous acclaim for her work as a result.

There was independent testing throughout Europe, in the UK and in the US thereafter. Cases where Dr Aslan’s methods were followed by researchers yielded the same incredible results, but where they did not (and it would be reasonable to ask why they did not) results were minimal and arrived at using only Procaine but not the buffering agents. It is strange, therefore, that even to this day in America only these inconclusive results have been widely published. Why not the positive results when they certainly existed.

Unfortunately it is not particularly worthwhile asking "why", as those who purposely published false conclusions decrying GH3 are not in the business of explaining their reasons of motives. Furthermore, that is not the end of the story.

In terms of GH3, the floodgates were open, with many countries accepting Dr Aslan’s claims, having reached their respective conclusions as a result of carrying out their own research. Currently numerous countries offer GH3 to their citizens, usually without prescription, and an estimated fifty million people have enjoyed the benefits of the product to some degree.

In America, an intern working with Dr Aslan named a Dr Sapse, who never forgot the evidence of his own eyes, approached the Food and Drug Administration (FDA) with the aim of obtaining pre-market permission to test GH3 as an anti-depressant for the elderly.

This granted, Dr Sapse raised funds to start his company (Rom-Amer) to market GH3. However, no sooner was the machinery in motion than the FDA changed the rules! Sensationalist media headlines such as "The Elixir of Life", "Will we live for ever" and other such flights of editorial fancy alarmed them so much that they informed Sapse that he would have to research the product on a huge number of patients over a limitless number of years in order to confirm these claims. He protested that his interest was limited to one factor, but the FDA’s decision was final. The financial ramifications of this change of heart by the FDA were such that the doctor was unable to continue, and his company declared bankrupt.

It is difficult to determine the FDA’s reasons for blocking developments, given that the anti-depressant aspect of GH3 was the focus, and that the Authority itself had decided the product (based on American research) was safe – an opinion that is maintained to this day, it is important to point out. As with all bureaucratic institutions, the FDA feels that it operates at a higher level than mere public interest, and is not disposed to explaining its decisions to the general public, whose interests it was originally established to serve. As a result we have to reach our own conclusions as to what the truth may be, which is easier than might be thought.

If we assume that GH3 works – and there is overwhelming evidence resulting from research that it does – then we have to consider the potential effects of this seemingly beneficial nutrient if it were to be generally available here as it already is (and has been for some 20 years) in most developed countries of the world, including those of the communist bloc, where at one time there was no money to be made from medications of this nature as the health industry was state run and state owned.

The answer lies in the fact that GH3 does work; not only that, but it works "across the board"  on a number of conditions and diseases that seem unrelated and which are being "treated"  by a growing range of very expensive and unnatural drugs which also carry the risk of a growing number of side-effects, which are themselves treated with more unnatural drugs, which produce more side-effects, which are then treated by… and so on, and so on.

The suppression of competitive or threatening products and materials is commonplace in all large global industries. For years the introduction of the recording tape was postponed by the disc manufacturers as the new product would have dramatically reduced their sales. Similarly a  carburettor, patented in 1933 and resulting in fuel consumption of more than 200 miles per gallon when fitted to a fuel-thirsty Ford , with greater power output!, vanished off the scene as soon as it was mentioned in the press.

However, one group cannot be isolated as being the only factor blocking GH3; they require help to keep the product off the market, and could not do it alone. Who would be able to provide this held help? Why, those with the governmental authority to rule on such matters – The Food and Drug Administration. And what of the American Medical Association? The reluctance of these two powerful entities to implement swift and accurate research (using GH3 not procaine) to "satisfy themselves" of what has been known in the rest of the world for two decades must have a reason. Here again we must cite vested interest. And what of the effectiveness of the drugs the FDA is so keen to promote throughout the health industry? Is it not the case that the use of unnatural drugs has spawned an entire new financial bonanza. One in which the public is now prescribed lethal and near lethal substances to "treat symptoms" rather than receiving help to cure their conditions! Drugs which can only save then from terminal disease by killing then ahead of the natural process - as is the case more often than not with chemotherapy and cancer surgery! Any patient who is continually receiving highly expensive treatment for his symptoms is worth much more to the medical industry than one who is cured.

A fair question to ask would be: what is the American Medical Association’s opinion of GH3? The truth is the Association has managed to totally ignore the product very effectively – a stark and shameful contrast to the attitudes of their more enlightened counterparts overseas.

Readers have to decide for themselves. None of the aforementioned are likely to explain the reasons behind their actions, so the product’s effectiveness remains a matter of opinion. However, it is undeniably appalling that we are not talking of the suppression of a kitchen gadget which might make life just a little more convenient for those able to afford it, but of what seems to be a clear example of a totally mercenary decision to benefit from a constantly rising tide of human misery for the single and basic reason that – PROFITS COME FIRST!

Our grateful thanks to those in whom we place our trust.

By any standards Dr Aslan is a credit to herself, her profession and her nation. By bringing countless benefits to innumerable people, she has made her mark in a profound and unique way. The Nobel Committee did not honour Professor Aslan, despite the fact that many are those who have been so honoured with far less reason than she. Political corruption does not know national boundaries, and those who choose to deny her recognition proclaim only their inherent dishonesty.
 

PROFESSOR ANA ASLAN M.D., D.Sc.

General Director of the National Institute of Gerontology and Geriatrics, Bucharest Romania.
 Commemorative Gold Medal, Nicaragua.
Member of the Diplomatic Academy of Peace
Merit Cross First Class, of the Order of Merit of the Federal Republic of Germany
Merito della Republico, Commander Degree, Italy

Extraordinary Professor Diploma of the First International Course for Improvements in Gerontology and Geriatrics Fuengirola, Spain.
 Medal of the Red Cross, Venezuela
Knight of New Europe
Honorary Member of the Association for Psychotherapy and Psycho-social researches,

Honorary Member of the Association "Rinnovamento Medico" awarded by the Accademia Lancisiana, Rome, Italy.
Athens, Greece.
Doctor Emeritus of Romania

"Pro Mundi Benefice" Medal - Brazilian Academy of Human Sciences Brazil
"De Orange Nassau" Order in Commander Degree, Holland
(and 25+ other honours).

[ T O P ]

GEROVITAL (GH3) – HOW DOES IT WORK?

According to Professor Aslan GH3 works in the human body at a "cellular level" – a phrase requiring some clarification.

The body is comprised of different types of cells (skin, muscle, brain, nerve, bone, and so on).

In the womb cells multiply to form a child. After birth the formation of new cells continues to occur while some cells die, with a process of exchange and regeneration taking place. As long as more cells are being formed than are dying we continue to grow. This process continues until we reach our early 20s, at which time the rates at which new cells form and old cells die are equal. In their 30s people lose more cells than they gain, and a decline in overall health and efficiency begins which accelerates in pace the older a person becomes. There are methods of reducing the speed of deterioration, such as careful dieting, engaging in physical exercise, clean living, and so on, but these are very often unattractive or unrealistic propositions for the average person. On the other hand, there are also many remarkable men and women aged 60 years or more who have preserved themselves to the extent that they have the appearance and physical and mental abilities of a 30 year old.

When the cellular exchange rate tips towards a daily loss the functions of both body and brain begin to deteriorate. The commencement of this process is virtually unnoticeable to most, the exceptions being those who have, for example, an inherent weakness such as a liver in poor condition through over consumption of alcohol, or lungs affected by smoking – these will be the areas in which bodily degeneration is most likely to be first manifest. Their lack of basic good health will result in an inability to serve the body efficiently and this will of course result in problems becoming apparent. If vital organs should fail altogether the condition could well be terminal, depending on the organ or organs in question and the means of treatment that might be available. This, then, is the level at which GH3 does its remarkable work. Through its ability to feed, rejuvenate and even replenish the cells, the ravages of life and the decline of the body through advancing years can be slowed down, and even in many cases reversed. The majority of those treated with GH3 look and feel younger than their counterparts who do not use the product.

Obviously do not actually become younger – a glance at their birth certificates will confirm this – and neither will they live forever! But nonetheless, the general effect of GH3 is the maintenance of a much more healthful bodily and mental state than would otherwise be the case. Those who use GH3 are able to enjoy the Indian Summer of their lives rather than become a physical and/or mental derelict in their latter years, leading a life without dignity, being a burden to those around them and an embarrassment to themselves.

Of course it also follows that GH3 has similarly remarkable effects on the cells of those with health problems. By feeding the cells it counters the effects of any condition which could be described as unnatural to normal bodily function, be it physical or mental. And because the product works via the circulatory system, through the blood – the great transport system (for good or evil) on which we totally depend – it can and often does produce unique results in a way which can be duplicated by no other known substance.

As we know, procaine is the "active ingredient" in GH3. It consists of two substances found naturally in the body – PABA and DEAE – which belong to the B vitamin complex. The secret of GH3 is that, when combined, these two substances are infinitely more beneficial than when separate, and it is this fact that gave rise to the description "H3", originally used to describe the powerful factor contained within the procaine molecule.

Exactly why GH3 does its wondrous work Professor Aslan and her colleagues were unable to determine, and thus they decided that as the chemical term for PABA is H1 and Folic acid (also produced in the body) is H2, their nutrient should be known as H3 – a decision that would result in confusion in the future. Using a substance which works but whose properties cannot be fully analysed is not new to the healing arts, Aspirin being a case in point.

GH3 was therefore procaine (the "active ingredient") buffered and stabilised through the addition of Benzoic acid as a preservative and potassium metabisulphite as an antioxidant. While straight procaine has a pH factor of seven, GH3 has one of 3.3. This makes it an acidulous balance, which ensures the prolonged stabilisation so crucial to the product’s efficacy, and which also eliminates its unwanted anaesthetic qualities.

In the intestine GH3 breaks down into its constituent parts (PABA and DEAE) and these play vitally important roles prior to final metabolisation. PABA stimulates "good" intestinal flora to produce vitamin B and also Folic acid, whilst DEAE helps generate choline and acetlycholine, which are both essential for the health and effectiveness of the spleen, liver, brain and nerve synapses.

In particular, DEAE normalises the level of monoamine oxidase (MAO) in the brain, thereby counteracting depression. (Note: MAO is produced in the body and controls the level of neurohormones.) Around middle age MAO levels increase in many people, and this is known to be a major cause of depression. DEAE’s unique quality is that it is a reversible inhibitor of MAO, while all other medications currently in use are irreversible in their action. In other words they lower the level of MAO by destroying the mechanism that produces it in the first place. The side effects for a body without MAO are extremely severe, and can include death from brain haemorrhage. GH3 has no side effects – it is totally safe.

As DEAE counteracts depression it also provides mental stimulation, a feeling of "well being" and, unlike amphetamines (which are in any case alien to the human body) has no adverse side effects or "rebound" period of depression. Through working at cellular level GH3 has the ability to influence both body and brain in a wide variety of ways. The body in fact possesses what is described as a "Homeostatic Balance", that is a sort of "internal clock". This can also be thought of as a three-dimensional thermostat regulating every bodily function, working to eliminate any "unnatural" mental or physical condition. GH3 has the capability (and remember the actual reason is unknown) to work towards this balancing process with complete success. This is to a great extent achieved by its capacity not only to increase supply throughout the entire circulatory system at the same time, but to increase by up to 30% the oxygen capacity of the red corpuscles. This serves to strengthen the immune system, thereby increasing resistance to any type of infection.

Research shows that a huge number of conditions – especially age-related – have at some time been observed to respond beneficially to GH3.

[ T O P ]

GH3 FORMULA: THE FUNCTION OF ITS CONSTITUENTS

Procaine: breaks down in the body into its two elements –

(1) PABA – stimulates "good" intestinal flora to produce vitamins B and K and Folic acid.

(2) DEAE – generates choline and acetlycholine, both essential to the effective function of spleen, liver, brain and nerve impulse relays. It also normalises the level of mono-amine oxidase (MAO) in the brain, thereby functioning as an anti-depressant.

METABISULPHITE: has a blood cleaning and artery cleaning effects and helps reduce hypertension.

POTASSIUM: stabilises the procaine molecule to extend and reinforce its action on the nervous system.

SODIUM: works primarily as a buffering agent to protect the procaine whilst it works within the body.

BENZOIC ACID/POTASSIUM METABISULPHITE: Stabilises the pH value of GH3 at between 3 and 3.3 (aciduous).

A QUESTION OF CHOICE

It has been established that Gerovital H3 is possibly the most exciting medical discovery since the principles of medical hygiene were reluctantly accepted by the profession in the 19th century.

It is clearly undesirable to accept any new substance or therapy without first entering into careful and highly qualified investigation. It is equally undesirable, indeed unacceptable, to deliberately ignore the potential of a product as efficacious as GH3, and refuse to accept the huge amount of irrefutable evidence supporting it – and then stipulate a need for the provision of "irrefutable evidence" before "approval" for use may be given!

This is the absurd position into which GH3 has been pegged by the Food and Drug Administration in the US for many years. As stated by the FDA on numerous occasions, its safety is unquestioned (San Diego Union 22 May 1979 - Los Angeles Times 3 January 1980). Furthermore, they have been thrown out of court more than once for attempting to claim authority over procaine, despite being aware they cannot do this as the product was in general use long before the body was established.

Whether you, the reader, are 150% in favour of chemotherapy, Nutritional therapy,  Aloe Vera or anything else is irrelevant. The simple fact is that you have an inalienable right to decide what form of treatment you should receive. This includes any or all of the aforementioned treatments – and most certainly includes the superb, proven benefits offered by Gerovital H3!

Stand up for your rights, my friends. Do not be browbeaten, bullied or harassed into accepting anything other than your choice. Demand information regarding the potential side-effects of any unnatural drug prescribed for you, and above all, do not become a statistic, one of those who, due to irreversible and progressive damage arising from unnatural drug therapy, can only look forward to a future of ill health and infirmity.

IT'S YOUR RIGHT TO CHOOSE !